SG Americas Securities, LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 216 filers reported holding DENALI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$739
+163.9%
35,800
+277.9%
0.01%
+300.0%
Q2 2023$280
-67.4%
9,474
-74.6%
0.00%
-80.0%
Q1 2023$859
+581.7%
37,291
+720.3%
0.01%
+400.0%
Q4 2022$126
-100.0%
4,546
-64.6%
0.00%
-60.0%
Q3 2022$394,000
-65.9%
12,851
-67.3%
0.01%
-58.3%
Q2 2022$1,157,000
+300.3%
39,316
+337.8%
0.01%
+500.0%
Q1 2022$289,000
-80.2%
8,980
-72.6%
0.00%
-75.0%
Q4 2021$1,463,000
-6.2%
32,802
+6.2%
0.01%
+14.3%
Q3 2021$1,559,000
+15.1%
30,895
+78.9%
0.01%
+16.7%
Q2 2021$1,355,000
-12.7%
17,270
-36.5%
0.01%
-25.0%
Q1 2021$1,552,000
-27.7%
27,178
+6.1%
0.01%
-27.3%
Q4 2020$2,146,000
-28.0%
25,619
-69.2%
0.01%
-42.1%
Q3 2020$2,979,000
+504.3%
83,147
+308.0%
0.02%
+375.0%
Q2 2020$493,000
+26.4%
20,381
-8.5%
0.00%0.0%
Q1 2020$390,000
+47.2%
22,286
+46.6%
0.00%
+100.0%
Q4 2019$265,000
-50.7%
15,200
-56.7%
0.00%
-50.0%
Q3 2019$538,000
+174.5%
35,110
+271.8%
0.00%
+300.0%
Q2 2019$196,000
-5.8%
9,442
+5.2%
0.00%
-50.0%
Q1 2019$208,0008,9750.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Crestline Management, LP 7,460,732$240,012,00028.78%
Casdin Capital, LLC 1,500,000$48,255,0002.16%
Flagship Pioneering Inc. 2,619,968$84,284,0001.98%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 38,000$8,192,0001.85%
Yiheng Capital Management, L.P. 1,014,684$32,642,0001.49%
SECTORAL ASSET MANAGEMENT INC 207,100$6,662,0001.18%
Artal Group S.A. 600,000$19,302,0000.81%
GILDER GAGNON HOWE & CO LLC 2,619,217$84,260,0000.78%
Temasek Holdings (Private) Ltd 5,369,487$172,736,3970.73%
BRANDYWINE MANAGERS, LLC 9,601$309,0000.53%
View complete list of DENALI THERAPEUTICS INC shareholders